Topical roflumilast 0.3% foam
2020-527
Phase 2 small_molecule active
Quick answer
Topical roflumilast 0.3% foam for Hidradenitis Suppurativa is a Phase 2 program (small_molecule) at Arcutis Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Arcutis Biotherapeutics
- Indication
- Hidradenitis Suppurativa
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active